Bajaj Healthcare Limited — Updates, 20-07-2026: Press Release
20-07-2026 | 08:50 pm
20-07-2026 | 08:50 pm
Bajaj Healthcare's Q1 FY27 revenue grew 11.3% to Rs. 165.6 Cr, with PAT up 15.8% to Rs. 13.7 Cr. Domestic API sales surged 27%. A key milestone for Cenobamate Tablets, a next-gen anti-seizure drug, was secured. An expanded R&D centre is now operational.
No comments yet. Be the first to comment!
